Literature DB >> 22968485

Muscle inflammatory signaling in response to 9 days of physical inactivity in young men with low compared with normal birth weight.

Martin Friedrichsen1, Rasmus Ribel-Madsen, Brynjulf Mortensen, Christina N Hansen, Amra C Alibegovic, Lise Højbjerre, Mette P Sonne, Jørgen F P Wojtaszewski, Bente Stallknecht, Flemming Dela, Allan Vaag.   

Abstract

OBJECTIVE: The molecular mechanisms linking physical inactivity and muscle insulin resistance in humans have been suggested to include increased muscle inflammation, possibly associated with impaired oxidative metabolism. We employed a human bed rest study including 20 young males with normal birth weight (NBW) and 20 with low birth weight (LBW) and increased risk of diabetes.
METHODOLOGY: The subjects were studied before and after 9 days of bed rest using the euglycemic-hyperinsulinemic clamp and muscle biopsy excision. Muscle inflammatory status was assessed as nuclear factor-κB (NF-κB) activity and mRNA expression of the pro-inflammatory MCP1 (CCL2) and IL6 and the macrophage marker CD68. Furthermore, mRNA expression of genes central to oxidative phosphorylation (OXPHOS) was measured including ATP5O, COX7A1, NDUFB6, and UQCRB.
RESULTS: At baseline, muscle inflammatory status was similar in NBW and LBW individuals. After bed rest, CD68 expression was increased in LBW (P=0.03) but not in NBW individuals. Furthermore, expression levels of all OXPHOS genes were reduced after bed rest in LBW (P ≤ 0.05) but not in NBW subjects and were negatively correlated with CD68 expression in LBW subjects (P ≤ 0.03 for all correlations). MCP1 expression and NF-κB activity were unaffected by bed rest, and IL6 expression was too low for accurate measurements. None of the inflammatory markers correlated with insulin sensitivity.
CONCLUSIONS: Although LBW subjects exhibit disproportionately elevated CD68 mRNA expression suggesting macrophage infiltration and reduced OXPHOS gene expression when exposed to bed rest, our data altogether do not support the notion that bed rest-induced (9 days) insulin resistance is caused by increased muscle inflammation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968485     DOI: 10.1530/EJE-12-0498

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  5 in total

1.  Aging-related effects of bed rest followed by eccentric exercise rehabilitation on skeletal muscle macrophages and insulin sensitivity.

Authors:  Paul T Reidy; Catherine C Lindsay; Alec I McKenzie; Christopher S Fry; Mark A Supiano; Robin L Marcus; Paul C LaStayo; Micah J Drummond
Journal:  Exp Gerontol       Date:  2017-07-10       Impact factor: 4.032

2.  Physical activity is associated with retained muscle metabolism in human myotubes challenged with palmitate.

Authors:  C J Green; T Bunprajun; B K Pedersen; C Scheele
Journal:  J Physiol       Date:  2013-06-17       Impact factor: 5.182

Review 3.  From fatalism to mitigation: A conceptual framework for mitigating fetal programming of chronic disease by maternal obesity.

Authors:  Janne Boone-Heinonen; Lynne C Messer; Stephen P Fortmann; Lawrence Wallack; Kent L Thornburg
Journal:  Prev Med       Date:  2015-10-30       Impact factor: 4.018

4.  Immobilization rapidly induces muscle insulin resistance together with the activation of MAPKs (JNK and p38) and impairment of AS160 phosphorylation.

Authors:  Emi Kawamoto; Keiichi Koshinaka; Tatsuhiko Yoshimura; Hiroyuki Masuda; Kentaro Kawanaka
Journal:  Physiol Rep       Date:  2016-08

5.  Use of deep neural network ensembles to identify embryonic-fetal transition markers: repression of COX7A1 in embryonic and cancer cells.

Authors:  Michael D West; Ivan Labat; Hal Sternberg; Dana Larocca; Igor Nasonkin; Karen B Chapman; Ratnesh Singh; Eugene Makarev; Alex Aliper; Andrey Kazennov; Andrey Alekseenko; Nikolai Shuvalov; Evgenia Cheskidova; Aleksandr Alekseev; Artem Artemov; Evgeny Putin; Polina Mamoshina; Nikita Pryanichnikov; Jacob Larocca; Karen Copeland; Evgeny Izumchenko; Mikhail Korzinkin; Alex Zhavoronkov
Journal:  Oncotarget       Date:  2017-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.